1. Early and next‐generation KIT/PDGFRA kinase inhibitors and the future of treatment for advanced gastrointestinal stromal tumor;Bauer S.;Front. Oncol.,2021
2. https://clinicaltrials.gov.
3. Avapritinib: First approval;Dhillon S.;Drugs.,2020
4. Early and Next‐Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor;Bauer S.;Front. Oncol.,2021
5. Blueprint's Ayvakit expected to take Novartis’ Rydapt crown in advanced systemic mastocytosis but off‐label use in indolent unlikely;Rai‐Roche Sean;Clinical Trials Arena.,2021